- $2.03bn
- $2.22bn
- $1.25bn
- 79
- 65
- 46
- 68
Annual income statement for Livanova, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 934 | 1,035 | 1,022 | 1,154 | 1,253 |
| Cost of Revenue | |||||
| Gross Profit | 595 | 706 | 707 | 771 | 871 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,210 | 1,096 | 1,099 | 1,222 | 1,156 |
| Operating Profit | -275 | -61 | -76.8 | -68.5 | 97.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -348 | -124 | -75.1 | -81.2 | 88.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -347 | -136 | -86.2 | 17.6 | 63.3 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -349 | -136 | -86.2 | 17.5 | 63.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -349 | -136 | -86.2 | 17.5 | 63.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.19 | -1.3 | 0.312 | 1.83 | 2 |